|
2024
|
Invention
|
Fast dissolving softgel capsules.
Disclosed in certain embodiments is a softgel capsule film com... |
|
|
Invention
|
Capsules for oral and nasal delivery of pharmaceutical products. Disclosed herein is a method inc... |
|
|
Invention
|
Method to relieve stress in capsule shells to reduce propensity to break.
A method of treating a... |
|
|
Invention
|
Tandem-cleavage linkers for antibody-drug conjugates and uses thereof. The present disclosure pro... |
|
|
Invention
|
Dual-payload antibody-drug conjugates and uses thereof. The present disclosure provides antibody-... |
|
|
Invention
|
Fast dissolving softgel capsules including ibuprofen. Disclosed in certain embodiments is a softg... |
|
|
Invention
|
Enteric bisacodyl softgel capsule.
Softgel capsules comprise a fill material and a shell composi... |
|
|
Invention
|
Coated enteric softgel capsules.
Disclosed herein is a softgel capsule including a fill material... |
|
|
Invention
|
Delayed release softgel capsules in higher ph environment.
Disclosed in certain embodiments is a... |
|
|
Invention
|
Softgel capsule including a non-steroidal anti-inflammatory drug and acetaminophen. Described her... |
|
|
Invention
|
Enteric softgel capsules.
Enteric softgel capsules comprise a fill material and an enteric shell... |
|
|
G/S
|
Business consulting services relating to product distribution, operations management services, lo... |
|
|
Invention
|
Improved adeno-associated virus vectors. The present invention relates AAV genomes, vectors and n... |
|
|
Invention
|
Two-plasmid system for aav vector particle production. CapRepRep and the gene of interest on a se... |
|
|
Invention
|
Ambroxol liquid formulation. Disclosed in certain embodiments is a liquid formulation for oral ad... |
|
|
Invention
|
Systems and methods for producing batch records for pharmaceutical trials. Embodiments of the pre... |
|
|
Invention
|
Methods for nucleic acid separation and analysis. The present invention relates to methods for th... |
|
|
Invention
|
Systems and methods for providing optimal process parameters for fluid bed granulation systems. A... |
|
|
Invention
|
Sulfatase-cleavable linkers for antibody-drug conjugates.
The present disclosure provides antibo... |
|
|
Invention
|
Antibody specific for mucin-1 and methods of use thereof.
The present disclosure provides antibo... |
|
|
Invention
|
Methods of differentiation of pluripotent stem cells into mesenchymal stromal cells. The inventio... |
|
|
Invention
|
Osmotic pharmaceutical capsules. Disclosed in certain embodiments is a capsule comprising a liqui... |
|
2023
|
Invention
|
Softgel capsules and a method for preparing the softgel capsules.
Disclosed herein is a method f... |
|
|
Invention
|
Softgel capsules and a method for preparing the softgel capsules. Disclosed herein is a method fo... |
|
|
Invention
|
Softgel capsule and method of marking a softgel capsule. A softgel capsule is provided including ... |
|
|
Invention
|
Softgel capsule and method of marking a softgel capsule.
A softgel capsule is provided including... |
|
|
Invention
|
Anti-cd25 antibody-maytansine conjugates and methods of use thereof.
The present disclosure prov... |
|
|
Invention
|
Systems and methods for aggregating supply orders for pharmaceutical trials. Embodiments of the p... |
|
|
Invention
|
Method of differentiation of pluripotent stem cells to hematopoietic precursor and stem cells. Th... |
|
|
Invention
|
Antibody conjugates and methods of making and using the same.
Antibodies that include a sulfatas... |
|
|
Invention
|
Fast dissolving softgel capsules. Disclosed in certain embodiments is a softgel capsule film comp... |
|
|
Invention
|
Coated enteric softgel capsules. Disclosed herein is a softgel capsule including a fill material,... |
|
|
Invention
|
Systems and methods for providing optimal process parameters for fluid bed granulation systems.
... |
|
2022
|
Invention
|
Pharmaceutical trials systems and methods.
Embodiments of the present disclosure include systems... |
|
|
G/S
|
Custom manufacture of pharmaceuticals, biopharmaceuticals, and oral drug formulations; manufactur... |
|
|
G/S
|
Custom manufacture of pharmaceuticals, biopharmaceuticals,
and oral drug formulations; manufactu... |
|
|
G/S
|
Custom manufacture of pharmaceuticals, biopharmaceuticals, and oral drug formulations; Manufactur... |
|
|
Invention
|
Tumor-associated calcium signal transducer 2 (tacstd2) antibody-maytansine conjugates and methods... |
|
|
Invention
|
Antibodies having humanized framework regions.
The present disclosure provides binding agents, p... |
|
|
Invention
|
Methods of using antibody-drug-conjugates.
This disclosure provides methods of using antibody-dr... |
|
|
Invention
|
Antibody-drug conjugates and methods of use thereof.
The present disclosure provides antibody co... |
|
|
Invention
|
Antibodies and antibody conjugates specific for nectin-4 and methods of use thereof.
The present... |
|
|
Invention
|
Softgel capsule.
A softgel capsule is provided which can be used with a fill composition includi... |
|
|
Invention
|
Humidity control device.
Provided are humidity control devices, systems, and methods of controll... |
|
|
Invention
|
Protective coating for moisture sensitive pharmaceutical compositions.
Provided are pharmaceutic... |
|
|
Invention
|
Methods of controlling cleavage of formylglycine-containing polypeptides.
Methods for reducing c... |
|
|
Invention
|
Anti-cd37 antibody-maytansine conjugates and methods of use thereof.
The present disclosure prov... |
|
|
Invention
|
Phospholipids as anion chelating agents in pharmaceutical formulations.
Disclosed herein are dos... |
|
|
Invention
|
Branched linkers for antibody-drug conjugates and methods of use thereof.
The present disclosure... |
|
|
Invention
|
Dual-cleavage ester linkers for antibody-drug conjugates.
The present disclosure provides antibo... |
|
2020
|
Invention
|
Non-animal softgel capsule formulations, methods of preparation, and methods of use thereof.
Dis... |
|
2018
|
G/S
|
Vitamins; mineral supplements and dietary supplements; Empty capsules used in the manufacture of ... |
|
2017
|
G/S
|
Laboratory chemicals for use in bioconjugation, reversible bioconjugation, irreversible bioconjug... |
|
2007
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
|
G/S
|
Drug delivery systems comprising polymer-based oral tablets for the continuous release of a wide ... |
|
|
G/S
|
Advertising; business management; business administration; office functions; business consulting ... |
|
2003
|
G/S
|
Vitamins; mineral supplements and dietary supplements |
|
2000
|
G/S
|
Soft gelatine capsules containing cosmetic preparations and cosmetic products in combination with... |
|
1986
|
G/S
|
EMPTY CAPSULES USED IN THE MANUFACTURE OF VITAMINS AND PHARMACEUTICAL PREPARATIONS |
